Status:
COMPLETED
Stromal Vascular Fraction (SVF) Injection in the Treatment of Patellar Tendinopathy
Lead Sponsor:
Istituto Ortopedico Rizzoli
Conditions:
Patellar Tendinitis
Tendinopathy
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
The aim of the study is the evaluation of clinical and radiological results after the treatment of patellar tendinopathy through the injection of autologous ultrasound-guided, intra- and peri-tendon s...
Detailed Description
After being informed about the study and potential risks, all patients giving written informed consent will be treated according to the study protocol. Every patients will undergo to a single peri- a...
Eligibility Criteria
Inclusion
- Ultrasound or MRI signs of patellar tendon pathology
Exclusion
- BMI \> 30
- Patients suffering from: rheumatic diseases, diabetes, infectious processes, epilepsy, severe osteoporosis
- Patients undergoing intra-tendon infiltration of another substance within the previous 6 months;
- Patients who had patellar tendon surgery within the previous 12 months;
- Immunodepression
- On going systemic inflammatory diseases (stabilized outcomes of such diseases are not considered absolute contraindications).
Key Trial Info
Start Date :
July 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 5 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04753853
Start Date
July 1 2021
End Date
May 5 2025
Last Update
September 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istituto Ortopedico Rizzoli
Bologna, Italy, 40124